12/18/2024
5:15 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:18 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:19 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:41 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
4:06 PM | Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/17/2024
3:53 PM | Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/16/2024
3:44 PM | Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
12/16/2024
3:15 PM | Arrowhead Pharmaceuticals (Subject)
GIVEN DOUGLAS B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
7:34 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
11/14/2024
8:38 AM | Arrowhead Pharmaceuticals (Subject)
Avoro Capital Advisors LLC (Filed by)
| Form SC 13G | |
10/16/2024
8:15 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
07/03/2024
4:27 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:04 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
1:39 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/10/2024
1:03 PM | Arrowhead Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
04/03/2024
5:05 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:30 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
6:06 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:38 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2024
6:00 PM | Arrowhead Pharmaceuticals (Issuer)
Lu Hongbo (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/08/2024
4:54 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:30 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024
4:25 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2024
3:57 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/26/2024
4:28 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEFA14A | |
01/24/2024
11:57 AM | Arrowhead Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/23/2024
3:14 PM | Arrowhead Pharmaceuticals (Subject)
BlackRock Inc. (Filed by)
| Form SC 13G/A | |
01/17/2024
5:32 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
4:22 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144/A | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Vakiener Victoria (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Ferrari Mauro (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
Waddill William D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
5:06 PM | Arrowhead Pharmaceuticals (Issuer)
GIVEN DOUGLAS B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:48 PM | Arrowhead Pharmaceuticals (Subject)
Vakiener Victoria (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
3:38 PM | Arrowhead Pharmaceuticals (Subject)
Arrowhead Pharmaceuticals (Subject)
Waddill William D. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/11/2024
3:22 PM | Arrowhead Pharmaceuticals (Subject)
Ferrari Mauro (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024
4:16 PM | Arrowhead Pharmaceuticals (Issuer)
San Martin Javier (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:16 PM | Arrowhead Pharmaceuticals (Issuer)
Myszkowski Kenneth Allen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:17 PM | Arrowhead Pharmaceuticals (Issuer)
Oliver Tracie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:58 PM | Arrowhead Pharmaceuticals (Issuer)
O'Brien Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
01/05/2024
7:02 PM | Arrowhead Pharmaceuticals (Issuer)
Hamilton James C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
4:33 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
4:14 PM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:39 PM | Arrowhead Pharmaceuticals (Subject)
Myszkowski Kenneth Allen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:21 PM | Arrowhead Pharmaceuticals (Subject)
San Martin Javier (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/05/2024
3:08 PM | Arrowhead Pharmaceuticals (Subject)
Oliver Tracie (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
4:25 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
4:27 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
12:49 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
12:06 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
12:25 PM | Arrowhead Pharmaceuticals (Subject)
O'Brien Patrick (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
11:24 AM | Arrowhead Pharmaceuticals (Subject)
Hamilton James C (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:44 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
4:04 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2023
3:34 PM | Anzalone Christopher Richard (Reporting)
Arrowhead Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free ARWR Stock Alerts